[628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDY
M. Peck-Radosavljevic, J. Boletis, F. Besisik, M. Lucia Ferra, L. Alric, D. Samuel, D. Messinger, H. Junker, H. CheinquerVolume:
46
Year:
2007
Language:
english
DOI:
10.1016/s0168-8278(07)62226-0
File:
PDF, 260 KB
english, 2007